Category Specific RSS

News

Beamtree bound to Canada with first major North American win

AI solutions provider for healthcare companies Beamtree Holdings (ASX: BMT) has won a significant contract bid with the Provincial Health…

3 years ago

Volpara teams up with BreastScreen Victoria to implement AI imaging for breast cancer

As medical technology continues to advance, digital imaging is now a staple for image interpretation for cancer diagnosis, especially in…

3 years ago

DigitalX’s Bitcoin Fund sees 4.5% decline as crypto markets brace for Binance lawsuit

A quick recap for anyone who is out of the crypto whirlpool: Last year, FTX (one of the largest crypto…

3 years ago

Avecho develops cannabis gummies, gears up to bring them to Australia

Biotech company Avecho (ASX: AVE) has completed the development of its first generation TPM gummies containing cannabinoids and is all…

3 years ago

Synlait receives permit renewal to supply baby formula to the Chinese market

China has emerged as a hotspot for baby formula export from Australia and New Zealand. Imported baby formula holds a…

3 years ago

Sigma Healthcare inks $3 billion supply deal with Chemist Warehouse via equity partnership

Retail pharmacy supplier Sigma Healthcare (ASX: SIG) - the Company behind Amcal and Discount Drug Stores - has struck a…

3 years ago

Southern Cross Electrical lands three data centre projects with Amazon, Microsoft and NEXTDC

Heyday is enjoying its heyday, signing on tech giants as clients once again. In a significant development, electrical engineering company…

3 years ago

Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer

In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New…

3 years ago

Starpharma gains regulatory approval in Malaysia for nasal spray to build momentum in Asia

Biopharmaceutical company Starpharma (ASX: SPL) has received regulatory approval for its antiviral nasal spray product, VIRALEZE, in Malaysia. This milestone…

3 years ago

Doctor Care Anywhere sells GP2U to focus on UK growth

As it departs from Australia to cement its base in the UK alone, telehealth company Doctor Care Anywhere Group (ASX:…

3 years ago